Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial | |
Huang, Yan; Cao, Xiaolong; Wang, Rensheng; Lu, Xiaojun; Chen, Dongping; Xu, Mingjun; Peng, Jiewen; Xi, Xuping; Lin, Qin; Xie, Conghua | |
刊名 | LANCET |
2016 | |
卷号 | 388期号:10054 |
ISSN号 | 0140-6736 |
DOI | 10.1016/S0140-6736(16)31388-5 |
URL标识 | 查看原文 |
收录类别 | SCIE ; ESI高被引论文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3737007 |
专题 | 武汉大学 |
推荐引用方式 GB/T 7714 | Huang, Yan,Cao, Xiaolong,Wang, Rensheng,et al. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial[J]. LANCET,2016,388(10054). |
APA | Huang, Yan.,Cao, Xiaolong.,Wang, Rensheng.,Lu, Xiaojun.,Chen, Dongping.,...&Zhang, Li.(2016).Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.LANCET,388(10054). |
MLA | Huang, Yan,et al."Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial".LANCET 388.10054(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论